nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—nerve—chronic kidney failure	0.0414	0.293	CbGeAlD
Vapreotide—SSTR2—renal system—chronic kidney failure	0.0221	0.157	CbGeAlD
Vapreotide—SSTR2—kidney—chronic kidney failure	0.0214	0.151	CbGeAlD
Vapreotide—SSTR2—digestive system—chronic kidney failure	0.0181	0.128	CbGeAlD
Vapreotide—TACR1—renal system—chronic kidney failure	0.0147	0.104	CbGeAlD
Vapreotide—TACR1—digestive system—chronic kidney failure	0.012	0.0853	CbGeAlD
Vapreotide—TACR1—blood—chronic kidney failure	0.0115	0.0813	CbGeAlD
Vapreotide—Desmopressin—PTGS1—chronic kidney failure	0.00506	0.636	CrCbGaD
Vapreotide—Desmopressin—PTGS2—chronic kidney failure	0.00289	0.364	CrCbGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NFKB1—chronic kidney failure	0.00259	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00255	0.00299	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—chronic kidney failure	0.00254	0.00298	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—EDN1—chronic kidney failure	0.00253	0.00297	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—POMC—chronic kidney failure	0.00251	0.00295	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL5—chronic kidney failure	0.00251	0.00295	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—chronic kidney failure	0.0025	0.00294	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—chronic kidney failure	0.00246	0.00289	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AVP—chronic kidney failure	0.00245	0.00288	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTH—chronic kidney failure	0.00241	0.00284	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic kidney failure	0.00241	0.00284	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CRHR1—chronic kidney failure	0.0024	0.00282	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—chronic kidney failure	0.00239	0.00281	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTH—chronic kidney failure	0.00238	0.00279	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00235	0.00276	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—chronic kidney failure	0.00235	0.00276	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—EDN1—chronic kidney failure	0.00233	0.00274	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00232	0.00273	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL5—chronic kidney failure	0.00232	0.00272	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—NPY—chronic kidney failure	0.00227	0.00267	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00227	0.00267	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR5—chronic kidney failure	0.00226	0.00266	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTH—chronic kidney failure	0.00219	0.00258	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CRH—chronic kidney failure	0.00219	0.00258	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—OXT—chronic kidney failure	0.00219	0.00258	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—chronic kidney failure	0.00218	0.00257	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—COL4A5—chronic kidney failure	0.00218	0.00256	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—chronic kidney failure	0.00216	0.00253	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00214	0.00252	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—chronic kidney failure	0.00212	0.00249	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—NPY—chronic kidney failure	0.0021	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00209	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR5—chronic kidney failure	0.00209	0.00245	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—NPS—chronic kidney failure	0.00208	0.00244	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CRHR1—chronic kidney failure	0.00208	0.00244	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NPY—chronic kidney failure	0.00206	0.00242	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—DRD1—chronic kidney failure	0.00204	0.0024	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NFKB1—chronic kidney failure	0.00204	0.00239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TFDP2—chronic kidney failure	0.00202	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CRH—chronic kidney failure	0.00202	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—OXT—chronic kidney failure	0.00202	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—chronic kidney failure	0.00201	0.00237	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—COL4A5—chronic kidney failure	0.00201	0.00236	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CRH—chronic kidney failure	0.00199	0.00234	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—OXT—chronic kidney failure	0.00199	0.00234	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00198	0.00233	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—chronic kidney failure	0.00198	0.00233	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—F2—chronic kidney failure	0.00194	0.00228	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AVP—chronic kidney failure	0.00193	0.00227	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—NPS—chronic kidney failure	0.00192	0.00225	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NPY—chronic kidney failure	0.0019	0.00224	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTH—chronic kidney failure	0.0019	0.00223	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—NPS—chronic kidney failure	0.00189	0.00222	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CRHR1—chronic kidney failure	0.00189	0.00222	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—DRD1—chronic kidney failure	0.00188	0.00221	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TFDP2—chronic kidney failure	0.00187	0.0022	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—DRD1—chronic kidney failure	0.00185	0.00217	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—chronic kidney failure	0.00185	0.00217	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—VEGFA—chronic kidney failure	0.00185	0.00217	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—EDN1—chronic kidney failure	0.00184	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—OXT—chronic kidney failure	0.00184	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CRH—chronic kidney failure	0.00184	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00183	0.00215	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL5—chronic kidney failure	0.00182	0.00214	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PGF—chronic kidney failure	0.0018	0.00212	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—F2—chronic kidney failure	0.00179	0.0021	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—POMC—chronic kidney failure	0.00177	0.00208	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—NPS—chronic kidney failure	0.00174	0.00205	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—chronic kidney failure	0.00173	0.00203	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTH—chronic kidney failure	0.00173	0.00203	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—DRD1—chronic kidney failure	0.00171	0.00201	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRKAG2—chronic kidney failure	0.0017	0.00199	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.00169	0.00198	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PGF—chronic kidney failure	0.00167	0.00196	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—NPY—chronic kidney failure	0.00165	0.00194	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00165	0.00194	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR5—chronic kidney failure	0.00164	0.00193	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—POMC—chronic kidney failure	0.00163	0.00192	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—chronic kidney failure	0.00162	0.00191	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—COL4A3—chronic kidney failure	0.00161	0.00189	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—chronic kidney failure	0.0016	0.00188	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—chronic kidney failure	0.0016	0.00187	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CRH—chronic kidney failure	0.00159	0.00187	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—OXT—chronic kidney failure	0.00159	0.00187	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—chronic kidney failure	0.00158	0.00186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—COL4A5—chronic kidney failure	0.00158	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—HBEGF—chronic kidney failure	0.00157	0.00185	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRKAG2—chronic kidney failure	0.00157	0.00184	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CRHR1—chronic kidney failure	0.00153	0.0018	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—NPS—chronic kidney failure	0.00151	0.00177	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AVP—chronic kidney failure	0.0015	0.00177	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NPY—chronic kidney failure	0.0015	0.00176	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—COL4A3—chronic kidney failure	0.00148	0.00174	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—DRD1—chronic kidney failure	0.00148	0.00174	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LRP2—chronic kidney failure	0.00147	0.00173	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TFDP2—chronic kidney failure	0.00147	0.00173	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—HBEGF—chronic kidney failure	0.00145	0.00171	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CRH—chronic kidney failure	0.00145	0.0017	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—OXT—chronic kidney failure	0.00145	0.0017	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PIP5K1B—chronic kidney failure	0.00144	0.00169	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—EDN1—chronic kidney failure	0.00143	0.00168	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL5—chronic kidney failure	0.00142	0.00167	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CRHR1—chronic kidney failure	0.00142	0.00166	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—F2—chronic kidney failure	0.00141	0.00166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTH—chronic kidney failure	0.0014	0.00165	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AVP—chronic kidney failure	0.00139	0.00163	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—NPS—chronic kidney failure	0.00137	0.00161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CYBB—chronic kidney failure	0.00137	0.00161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AVP—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LRP2—chronic kidney failure	0.00136	0.0016	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—DRD1—chronic kidney failure	0.00134	0.00158	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—EDN1—chronic kidney failure	0.00132	0.00155	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PGF—chronic kidney failure	0.00131	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL5—chronic kidney failure	0.00131	0.00154	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EDN1—chronic kidney failure	0.0013	0.00153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—FGF23—chronic kidney failure	0.00129	0.00152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTH—chronic kidney failure	0.00129	0.00152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL5—chronic kidney failure	0.00129	0.00151	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—POMC—chronic kidney failure	0.00128	0.00151	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—chronic kidney failure	0.00128	0.0015	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR5—chronic kidney failure	0.00128	0.0015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CYBB—chronic kidney failure	0.00126	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AVP—chronic kidney failure	0.00126	0.00148	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—chronic kidney failure	0.00126	0.00148	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRKAG2—chronic kidney failure	0.00123	0.00145	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NPY—chronic kidney failure	0.00122	0.00143	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.00122	0.00143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EDN1—chronic kidney failure	0.0012	0.00141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—FGF23—chronic kidney failure	0.0012	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL5—chronic kidney failure	0.00119	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR5—chronic kidney failure	0.00118	0.00139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CRH—chronic kidney failure	0.00118	0.00138	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—OXT—chronic kidney failure	0.00118	0.00138	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—COL4A3—chronic kidney failure	0.00117	0.00137	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR5—chronic kidney failure	0.00116	0.00136	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—HBEGF—chronic kidney failure	0.00114	0.00134	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NCF1—chronic kidney failure	0.00113	0.00132	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NPY—chronic kidney failure	0.00112	0.00132	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CRHR1—chronic kidney failure	0.00111	0.00131	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NPS—chronic kidney failure	0.00111	0.00131	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—F2—chronic kidney failure	0.0011	0.00129	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—DRD1—chronic kidney failure	0.00109	0.00128	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AVP—chronic kidney failure	0.00109	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CRH—chronic kidney failure	0.00109	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—OXT—chronic kidney failure	0.00109	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR5—chronic kidney failure	0.00107	0.00126	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LRP2—chronic kidney failure	0.00107	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CYBA—chronic kidney failure	0.00106	0.00124	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NCF1—chronic kidney failure	0.00104	0.00122	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—EDN1—chronic kidney failure	0.00104	0.00122	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL5—chronic kidney failure	0.00103	0.00121	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NPS—chronic kidney failure	0.00103	0.00121	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTH—chronic kidney failure	0.00102	0.0012	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—F2—chronic kidney failure	0.00101	0.00119	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—DRD1—chronic kidney failure	0.00101	0.00119	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—POMC—chronic kidney failure	0.000998	0.00117	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—F2—chronic kidney failure	0.000995	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CYBB—chronic kidney failure	0.000994	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AVP—chronic kidney failure	0.000991	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.000989	0.00116	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CYBA—chronic kidney failure	0.000977	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EDN1—chronic kidney failure	0.000943	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—FGF23—chronic kidney failure	0.000941	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL5—chronic kidney failure	0.000936	0.0011	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HBEGF—chronic kidney failure	0.00093	0.00109	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR5—chronic kidney failure	0.000928	0.00109	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—POMC—chronic kidney failure	0.000921	0.00108	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—F2—chronic kidney failure	0.000918	0.00108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—POMC—chronic kidney failure	0.000907	0.00107	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—chronic kidney failure	0.000887	0.00104	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPY—chronic kidney failure	0.000886	0.00104	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HBEGF—chronic kidney failure	0.000858	0.00101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CRH—chronic kidney failure	0.000854	0.001	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—OXT—chronic kidney failure	0.000854	0.001	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR5—chronic kidney failure	0.000843	0.000991	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—POMC—chronic kidney failure	0.000837	0.000983	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—chronic kidney failure	0.000819	0.000962	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF1—chronic kidney failure	0.000818	0.000962	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NPS—chronic kidney failure	0.00081	0.000952	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AVP—chronic kidney failure	0.000806	0.000947	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—F2—chronic kidney failure	0.000796	0.000936	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—DRD1—chronic kidney failure	0.000794	0.000934	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CYBA—chronic kidney failure	0.000769	0.000904	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EDN1—chronic kidney failure	0.000767	0.000901	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL5—chronic kidney failure	0.000761	0.000894	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LPL—chronic kidney failure	0.000744	0.000874	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AVP—chronic kidney failure	0.000744	0.000874	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—POMC—chronic kidney failure	0.000725	0.000853	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—F2—chronic kidney failure	0.000723	0.00085	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EDN1—chronic kidney failure	0.000707	0.000831	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NGF—chronic kidney failure	0.000704	0.000828	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL5—chronic kidney failure	0.000702	0.000825	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LPL—chronic kidney failure	0.000686	0.000807	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR5—chronic kidney failure	0.000685	0.000805	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HBEGF—chronic kidney failure	0.000675	0.000794	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—POMC—chronic kidney failure	0.000659	0.000774	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NGF—chronic kidney failure	0.00065	0.000764	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—chronic kidney failure	0.000645	0.000758	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR5—chronic kidney failure	0.000632	0.000743	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—F2—chronic kidney failure	0.000588	0.000691	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AVP—chronic kidney failure	0.000586	0.000688	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDN1—chronic kidney failure	0.000557	0.000655	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IRS1—chronic kidney failure	0.000556	0.000654	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL5—chronic kidney failure	0.000553	0.00065	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—F2—chronic kidney failure	0.000543	0.000638	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LPL—chronic kidney failure	0.00054	0.000635	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—POMC—chronic kidney failure	0.000536	0.000629	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—chronic kidney failure	0.000524	0.000616	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IGF1—chronic kidney failure	0.000515	0.000605	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IRS1—chronic kidney failure	0.000513	0.000603	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NGF—chronic kidney failure	0.000512	0.000602	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR5—chronic kidney failure	0.000498	0.000585	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—POMC—chronic kidney failure	0.000494	0.000581	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SERPINE1—chronic kidney failure	0.000489	0.000575	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—KRAS—chronic kidney failure	0.000484	0.000569	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—chronic kidney failure	0.000484	0.000568	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IGF1—chronic kidney failure	0.000475	0.000559	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—chronic kidney failure	0.000467	0.000549	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SERPINE1—chronic kidney failure	0.000451	0.000531	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—KRAS—chronic kidney failure	0.000447	0.000525	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RELA—chronic kidney failure	0.00044	0.000517	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—chronic kidney failure	0.000431	0.000507	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2—chronic kidney failure	0.000427	0.000502	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RELA—chronic kidney failure	0.000406	0.000477	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IRS1—chronic kidney failure	0.000404	0.000475	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—chronic kidney failure	0.000394	0.000463	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—POMC—chronic kidney failure	0.000389	0.000457	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—chronic kidney failure	0.000381	0.000447	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IGF1—chronic kidney failure	0.000374	0.00044	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKB1—chronic kidney failure	0.000371	0.000436	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—chronic kidney failure	0.000364	0.000427	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SERPINE1—chronic kidney failure	0.000355	0.000418	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—KRAS—chronic kidney failure	0.000352	0.000414	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKB1—chronic kidney failure	0.000342	0.000402	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—chronic kidney failure	0.000339	0.000399	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—chronic kidney failure	0.000336	0.000395	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RELA—chronic kidney failure	0.000319	0.000375	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—chronic kidney failure	0.000311	0.000365	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—chronic kidney failure	0.000309	0.000363	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—chronic kidney failure	0.000286	0.000336	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—KRAS—chronic kidney failure	0.000286	0.000336	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—chronic kidney failure	0.000285	0.000335	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKB1—chronic kidney failure	0.000269	0.000317	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—KRAS—chronic kidney failure	0.000264	0.00031	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—chronic kidney failure	0.000244	0.000287	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—chronic kidney failure	0.000233	0.000274	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—chronic kidney failure	0.000224	0.000264	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—chronic kidney failure	0.000215	0.000252	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—KRAS—chronic kidney failure	0.000208	0.000244	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—chronic kidney failure	0.000169	0.000199	CbGpPWpGaD
